United States of America v. Donovan

CourtDistrict Court, E.D. New York
DecidedSeptember 17, 2020
Docket1:12-cv-05142
StatusUnknown

This text of United States of America v. Donovan (United States of America v. Donovan) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America v. Donovan, (E.D.N.Y. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ----------------------------------------------------------------X UNITED STATES OF AMERICA and NEW YORK STATE, ex rel. Irina Gelman, DPM,

Plaintiffs, REPORT AND RECOMMENDATION -against- 12-CV-5142-RJD-SJB

GLENN J. DONOVAN, DPM, NEW YORK CITY HEALTH and HOSPITALS CORPORATION and PHYSICIAN AFFILIATE GROUP OF NEW YORK, P.C.,

Defendants. ----------------------------------------------------------------X BULSARA, United States Magistrate Judge:

The parties have jointly filed a motion for approval of their settlement agreement (the “Settlement Agreement”) in this federal False Claims Act (“FCA”) and New York False Claims Act (“NY FCA”) qui tam action filed by Irina Gelman (“Gelman” or “Relator”), a former podiatry resident at Coney Island Hospital, on behalf of the United States and the State of New York (collectively, the “Government”), against Defendants Glenn J. Donovan, DPM (“Donovan”), the New York City Health and Hospitals Corporation (“NYC HHC”), and the Physician Affiliate Group of New York, P.C. (“PAGNY”) (collectively, “Defendants”). (Mot. for Settlement Approval dated June 29, 2020, Dkt. No. 122; Settlement Agreement and Order dated June 26, 2020 (“Settlement Agreement”), Dkt. No. 123; Parties’ Joint Mem. in Supp. of Mot. of Settlement Agreement dated July 16, 2020 (“Mem.”), Dkt. No. 124). The Amended Complaint alleges Defendants falsified patient records and program-accreditation papers to hide the fact that residents were not supervised while servicing hospital patients and some residents lacked licenses.1 The Settlement Agreement, effective on the date it is approved by the Court, is entered into by Donovan, NYC HHC, and Gelman to resolve all allegations in the Amended Complaint. (Settlement Agreement at 1, 4, 10–11). Per the Settlement

Agreement, Gelman agrees to dismiss PAGNY from the case with prejudice, and PAGNY is not a party to the Settlement Agreement. (Id. ¶ C). The Honorable Raymond J. Dearie referred the motion for settlement approval to the undersigned for a report and recommendation. (Mot. Referred dated June 29, 2020). The parties failed to submit a memorandum of law with their first motion for approval. The Court directed them to do so. (Order dated July 7, 2020 (“The parties filed a motion for settlement approval. The motion only contains the agreement between parties, but no legal memorandum demonstrating that the agreement is consistent with 31 U.S.C. § 3730. The parties shall submit a memorandum . . . by 7/21/2020. So Ordered by Magistrate Judge Sanket J. Bulsara on 7/7/2020.”) (citations

omitted)). On July 23, 2020, the Court denied the motion for approval without prejudice to renewal because the parties “failed to provide evidence that (1) Relator Gelman’s settlement recovery is reasonable and within the statutorily required ranges and (2) the amounts to be paid by Defendants for expenses are reasonable and were necessarily incurred and for attorney’s fees and costs are reasonable.” United States ex

1 For a complete recitation of the allegations, see the Memorandum and Order on Defendants’ motion to dismiss the Amended Complaint, United States ex rel. Gelman v. Donovan (Gelman I), No. 12-CV-5142, 2017 WL 4280543, at *1–4 (E.D.N.Y. Sept. 25, 2017). rel. Gelman v. Donovan (Gelman II), No. 12-CV-5142, 2020 WL 4251363, at *1 (E.D.N.Y. July 23, 2020). The Court permitted the parties to resubmit the Settlement Agreement for approval if they supported a renewed submission with arguments in a memorandum of law and declarations to support a conclusion “that Gelman’s recovery of settlement proceeds is between 25 and 30 percent of the federal FCA portion of the

settlement pursuant to 31 U.S.C. § 3730(d)(2), and between 25 and 30 percent of the NY FCA portion of the settlement pursuant to N.Y. State Fin. Law § 190(6)(b), a range of $312,500.00 and $375,000.00 when considering the entire settlement amount,” and that “expenses are reasonable and were necessarily incurred and such fees and costs are reasonable pursuant to 31 U.S.C. § 3730(d)(2) and N.Y. State Fin. Law § 190(6)(b).” Gelman II, 2020 WL 4251363, at *4. On August 4, 2020, Relator Gelman filed both a memorandum of law and a declaration from her counsel addressing the issues identified by the Court. (See Relator’s Suppl. Mem. of Law in Further Supp. of Settlement Agreement dated Aug. 4, 2020 (“Suppl. Mem.”), Dkt. No. 126; Decl. of Kevin P. Mulry in Supp. of Settlement Agreement dated Aug. 4, 2020 (“Mulry Decl.”), Dkt. No. 127). The additional

submission includes three agreements that were not previously provided and which operate in conjunction with the Settlement Agreement: (1) an agreement between Gelman and the United States for the payment of Relator’s share pursuant to the portion of the settlement to be paid to the United States, (Agreement Regarding Payment of Relator’s Share Between Relator Irina Gelman, DPM, and the United States dated June 5, 2020 (“Federal Recovery Agreement”), attached as Ex. B to the Mulry Decl., Dkt. No. 127); (2) an agreement between Gelman and the State of New York for Relator’s share from the New York portion of the settlement, (Agreement Regarding Payment of Relator’s Share Between Relator Irina Gelman, DPM and the State of New York dated July 7, 2020 (“State Recovery Agreement”), attached as Ex. C to the Mulry Decl., Dkt. No. 127); and (3) an agreement whereby NYC HHC and Donovan agree to pay certain fees, costs, and expenses to Gelman, (Agreement Regarding Payment of Attorneys’ Fees, Expenses, and Other Legal Costs dated June 26, 2020 (“Attorneys’ Fees and Costs

Agreement”), attached as Ex. D to the Mulry Decl., Dkt. No. 127). Defendants NYC HHC, PAGNY, and Donovon filed a letter stating they did not object to Plaintiffs’ submissions. (See Defs.’ Letter dated Aug. 6, 2020, Dkt. No. 128 at 1). And “[t]he attorneys for the United States and New York State were provided with the Attorneys’ Fees and Costs Agreement and advised that they had no objection to the attorneys’ fees and costs being paid.” (Mulry Decl. ¶ 30). For the reasons stated below, and in light of the supplemental submissions, the Court respectfully recommends that the settlement agreement be approved. DISCUSSION The FCA permits a private person to bring a qui tam action on behalf of the United States. 31 U.S.C. § 3730(b)(1). The statute “unambiguously states that a qui tam

action ‘may be dismissed only if the court and the Attorney General give written consent to the dismissal and their reasons for consenting.’” Mei Xing Yu v. Hasaki Rest., Inc., 944 F.3d 395, 401 (2d Cir. 2019) (quoting § 3730(b)(1)). The FCA is one of the “substantive statutes that specifically require[s] the district court’s consent before cases involving those statutory causes of action may be settled.” Id. “[T]his provision ‘applies only in cases where a plaintiff seeks voluntary dismissal of a claim or action brought under the False Claims Act, and not where the court orders dismissal.’” Chailla v. Navient Dep’t of Educ., 791 F. App’x 226, 229 (2d Cir. 2019) (quoting Minotti v. Lensink, 895 F.2d 100, 103 (2d Cir. 1990) (per curiam)), cert. denied, 140 S. Ct. 2527 (2020); e.g., United States ex rel. Mergent Servs. v. Flaherty,

Related

Minotti v. Lensink
895 F.2d 100 (Second Circuit, 1990)
United States Ex Rel. DRC, Inc. v. Custer
446 F. App'x 561 (Fourth Circuit, 2011)
Simmons v. New York City Transit Authority
575 F.3d 170 (Second Circuit, 2009)
United States Ex Rel. Mergent Services v. Flaherty
540 F.3d 89 (Second Circuit, 2008)
Caidor v. Onondaga County
517 F.3d 601 (Second Circuit, 2008)
United States Ex Rel. Ladas v. Exelis, Inc.
824 F.3d 16 (Second Circuit, 2016)
United States v. L-3 Communications EOTech, Inc.
921 F.3d 11 (Second Circuit, 2019)
Mei Xing Yu v. Hasaki Restaurant, Inc.
944 F.3d 395 (Second Circuit, 2019)
Fisher v. SD Protection Inc.
948 F.3d 593 (Second Circuit, 2020)
United States ex rel. Bibby v. Wells Fargo Bank, N.A.
369 F. Supp. 3d 1346 (N.D. Georgia, 2019)
Restivo v. Hessemann
846 F.3d 547 (Second Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
United States of America v. Donovan, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-v-donovan-nyed-2020.